Structural and functional characterization of DNAH5 variants in a Portuguese family with primary ciliary dyskinesia.

Researchers studying Primary Ciliary Dyskinesia (PCD) have long struggled with a diagnostic bottleneck: the "Variant of Uncertain Significance" (VUS). PCD is a rare genetic disorder. It affects the tiny, hair-like structures called cilia. These cilia act like biological brooms to clear mucus from the lungs. In PCD patients, these structures fail to beat correctly. While doctors can often identify the responsible genes, they frequently encounter mutations that are neither clearly healthy nor clearly broken.

This study from a Portuguese research team provides a blueprint for resolving these ambiguities. By investigating a single family, the authors report that a previously unclassified missense variant in the DNAH5 gene is actually pathogenic (disease-causing). They prove this by combining genetic sequencing with high-resolution structural modeling and protein expression analysis. This approach effectively turns a "maybe" into a definitive diagnosis.

The bottleneck of uncertain variants

Current diagnostic pipelines for PCD rely on a hierarchy of tests. These include measuring nasal nitric oxide levels, high-speed video microscopy of ciliary movement, and transmission electron microscopy (TEM) to examine the physical structure of the cilia. When these tests suggest disease, clinicians turn to genetic sequencing. However, the authors note that identifying biallelic pathogenic variants (two disease-causing mutations, one on each chromosome) in one of over 50 known genes is difficult. Many identified mutations fall into the VUS category.

A VUS is a genetic change that lacks sufficient evidence to be labeled as a cause of disease. For a clinician, a VUS is a dead end. It prevents a definitive diagnosis and complicates genetic counseling. The researchers argue that relying solely on genetic databases is insufficient. Instead, they propose an integrated approach. This method looks at how a mutation physically alters a protein's architecture. It also examines how that change affects the cell's ability to express that protein.

From sequence to structural instability

To solve the mystery of the DNAH5 c.5290 T>C p.(Ser1764Pro) variant, the authors moved beyond simple DNA reading. They entered the realm of molecular mechanics. The DNAH5 gene encodes a dynein protein. This is a molecular motor that generates the force required for cilia to beat. Think of dynein as the engine of the cilium. If the engine parts are warped, the broom won't sweep.

The researchers employed a multi-stage investigative process:

1. Genomic Identification: Using whole-exome sequencing (a method to sequence all protein-coding regions of the genome), the authors identified two variants in the proband (the first patient studied). These were a known pathogenic truncated variant and the suspected VUS.
2. Family Segregation: Through Sanger sequencing, they confirmed the proband inherited the truncated variant from his father and the VUS from his mother. This state is known as compound heterozygosity.
3. Structural Modeling: The authors used protein models from X-ray crystallography and cryo-electron microscopy to map the mutation sites.
4. Expression Analysis: Finally, they used immunofluorescence—a technique using fluorescently labeled antibodies to "light up" specific proteins—to see if the mutation reduced DNAH5 levels in the cilia.

The structural analysis was particularly revealing. The authors report that the Ser1764Pro mutation occurs within the Link3–4 region of the protein's N-terminal Linker. Specifically, the mutation replaces a serine with a proline. Proline has a unique cyclic structure. It acts like a rigid wedge that restricts the flexibility of the protein backbone. The paper finds that this substitution disrupts the regular hydrogen-bonding pattern of the $\beta$-sheet (a common structural motif in proteins) . This likely destabilizes the entire region.

Evidence of selective protein loss

The study connects microscopic structural flaws to macroscopic cellular failures. The authors report that the proband displayed hallmark PCD defects. His ciliary beat frequency was severely reduced to 0.66 Hz. This is far below the reference value of 12.75 Hz. He also showed a highly dyskinetic (abnormal) beating pattern. In this pattern, 62.5% of the cilia were completely immotile (unable to move).

The immunofluorescence data provided critical evidence for the VUS. Other structural proteins in the cilium remained present and correctly localized. These included DNALI1, GAS8, and RSPH9. However, the DNAH5 signal was markedly reduced .

The authors measured this using Corrected Total Cell Fluorescence (CTCF), which quantifies the brightness of the protein signal. They report a statistically significant reduction in DNAH5 intensity compared to control cells . This demonstrates that the mutation makes the protein unstable. The cell fails to maintain adequate levels of DNAH5 within the axoneme (the core structural assembly of the cilium).

Limitations in phenotype and scope

The study highlights the inherent complexity of genetic expression. The authors observe an intriguing mismatch in the family. Despite having the same two variants, the proband was fertile. In contrast, his brother experienced infertility. This suggests that a mutation is not a perfect predictor of clinical outcome. It points toward potential "gene interaction effects." In these cases, other parts of a person's genome might mitigate or exacerbate the defect.

The study is also limited by its small sample size. It focuses on a single family. This allowed for deep mechanistic insight. However, it makes it difficult to generalize the specific relationship between these variants and clinical severity. The authors also note that the proband's relatively low PICADAR score (a diagnostic predictive tool for PCD) may have contributed to his late diagnosis in his 40s. This suggests clinicians should remain vigilant even when traditional scoring systems appear borderline.

The verdict: integrate or stagnate

The evidence presented by the authors is compelling. By bridging the gap between a digital DNA sequence and a physical protein model, they have transformed a VUS into an actionable pathogenic marker. The combination of structural instability predictions and the empirical observation of reduced protein expression provides a robust framework.

For practitioners, the takeaway is clear. Genetic testing alone is often not enough to close a case. To resolve uncertainty in modern genomics, we must integrate molecular biology with structural physics. This study proves that the DNAH5 c.5290 T>C variant belongs in diagnostic panels. This provides a vital tool for the earlier and more accurate diagnosis of PCD.